BridgeBio Funding & Investors
Palo Alto, CA
BridgeBio Pharma, Inc. operates as a pharmaceutical company. The Company discovers and develops drugs for patients with grievous genetic diseases. BridgeBio Pharma offers medicines for different medical areas such as cardiology, neurology, oncology, and dermatology. BridgeBio Pharma serves patients in the State of California.
bridgebio.comTotal Amount Raised: $3,849,199,616
BridgeBio Funding Rounds
Post Ipo Equity
$250,000,000
Post Ipo Debt
$1,250,000,000
Post Ipo Debt Investors
Blue OwlCPPIB Credit InvestmentsPost Ipo Equity
$250,000,000
Post Ipo Equity Investors
Qatar Investment AuthorityPost Ipo Equity
$150,000,000
Post Ipo Debt
$750,000,000
Post Ipo Debt
$250,000,000
Post Ipo Debt
$475,000,000
Series D
$299,200,000
Series D Investors
KKRViking Global InvestorsHercules CapitalAisling CapitalCormorant CapitalAIG InvestmentsSequoia CapitalPerceptive AdvisorsIPO
Unknown
Series C
$135,000,000
Series C Investors
KKRViking Global InvestorsPerceptive AdvisorsAIG InvestmentsAisling CapitalCormorant CapitalJanus FundSeries B
$33,100,000
Series B Investors
KKRSeries B
$6,900,000
Series B Investors
KKR
Funding info provided by Diffbot.